Ordering a prenatal Test

All tests offered by HNL Genomics (CTGT) can be performed on prenatal specimens, including Nextgen sequencing, Sanger sequencing and deletion/duplication tests. HNL Genomics (CTGT) does not perform pre-implantation genetic diagnosis (PGD) on embryonic specimens. Clients are encouraged to contact us with any questions about ordering a prenatal test.

Specimen requirements

HNL Genomics (CTGT) prefers ONE of the following types of prenatal specimens:

  1. Prenatal cultured cells: Two confluent T-25 flasks derived from amnio or CVS samples.  Please fill all flasks to capacity with cell culture media before sending. HNL Genomics (CTGT) highly recommends the sender retain additional cell cultures until testing is completed. 
  2. Prenatal genomic DNA: a minimum of 3 µg at a concentration of at least 30 ng/µl, preferably in TE solution

Maternal cell contamination (MCC) studies

HNL Genomics (CTGT) highly recommends including a maternal sample for MCC studies with all prenatal tests. The maternal sample can be either whole blood in a purple-top (EDTA) tube or genomic DNA (a minimum of 3 µg). The maternal sample may be shipped to HNL Genomics (CTGT) separately if the fetal sample is not ready to be sent. 
Test code Test Price CPT Code
1389         Maternal cell contamination testing $370          81265 X 1 

Turnaround time (TAT)

HNL Genomics (CTGT) attempts to expedite all testing involving ongoing pregnancies. Our standard turnaround time for Sanger sequencing is approximately 1-2 weeks, for deletion/duplication tests approximately 2-3 weeks and approximately 2-4 weeks for NextGen sequencing.

Requisition form

HNL Genomics (CTGT) does not provide a separate requisition form for prenatal cases. Please complete the “Other Information” section on the last page of our requisition form and indicate that the sample is a prenatal specimen.


Prenatal specimens should be packed in materials that prevent the containers from being damaged during shipment. Specimen containers should be labeled with patient name and date of birth. Specimens sent without patient identifiers will not be accepted by HNL Genomics (CTGT). Prenatal and maternal specimens should be shipped at ambient temperature using an overnight delivery service. A complete requisition form, including payment information, must be sent with the specimens.

The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. HNL Lab Medicine strongly recommends confirmation of CPT codes with third-party payors and/or the AMA. We assume no responsibility for billing errors due to reliance upon CPT codes provided by HNL Lab Medicine.


October 28, 2022

Non-Hodgkin Lymphoma FISH Panel Now Available

B-cell lymphoma is a large group of heterogenous disorders and comprises a majority of non-Hodgkin lymphomas.
Read More
October 20, 2022

Genetic testing for Familial Transthyretin Amyloidosis (TTR) NOW AVAILABLE In-House

Hereditary amyloidosis is a life-threatening disorder that can lead to peripheral neuropathy and heart failure.
Read More
August 08, 2022

Familial hypercholesterolemia (FH)

Familial hypercholesterolemia (FH) is a genetic disorder that increases the likelihood of having coronary heart disease at a younger age. Learn about how to determine if you have hypercholesterolemia and what actions you can take to create better outcomes!

Read More
April 11, 2022

Genome Sequencing: A Vital Tool Used in Identifying and Tracking New COVID-19 Variants

Genome sequencing is reading or decoding the complete genetic information i.e. “Genome” of an organism that is encrypted in the form of a very long string called DNA made up of 4 letters, A, T, G, and C. The genome of an organism essentially determines their physical characteristics and ...
Read More
March 03, 2022

The Effect of Genetics on Individual Heart Health: Early Identification of FH Variations to Optimize Treatment

Test must be ordered by a Physician.

Familial hypercholesterolemia (FH) is a genetic disorder that is characterized by abnormally high blood levels of low-density lipoprotein (LDL) cholesterol, sometimes referred to as "bad cholesterol". This condition affects an estimated 1 in 250 people, and increases the likelihood of developing cardiovascular disease. In fact, FH is estimated to be the cause of 2-3% of heart attacks in individuals younger than age 60.

Read More